VANCOUVER, Oct. 29 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that it recently surpassed its 10,000th patient visit at its Centers for
Colorectal Health during 2007 compared to just over 1,000 patient visits for
the same period in 2006.
Commenting on this achievement, Edward Wright CEO of CRH Medical
Corporation stated, "Our 10,000th patient visit is a significant milestone as
it is further affirmation of the substantial demand for our technology and
treatment protocol in this underserved market of hemorrhoid treatment. As
previously announced, we expect to continue to open Centers in a number of new
markets to increase patient's accessibility to our services."
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented,
disposable, hemorrhoid banding system through its Center for Colorectal Health
facilities. According to the National Institute of Health approximately 50% of
the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening
its Center for Colorectal Health facilities in the United States specializing
in the treatment of hemorrhoids and fissures, and colon cancer screening and
plans to significantly increase the number of Centers for Colorectal Health
across the U.S. to address this underserved market. The Company's goal is to
become the preeminent resource on colorectal health for consumers and medical
professionals in North America.
The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes", "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
For further information:
For further information: call Dean Linden, Investor Relations, CRH
Medical Corporation at (604) 633-1440, or firstname.lastname@example.org; Additional
information may also be found by visiting the Company's website at
www.crhmedcorp.com or the SEDAR website at www.sedar.com